Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT02659527
Eligibility Criteria:
Inclusion Criteria:
* blood PSA level \> 4.0 ng/ml and
* free-to-total PSA ratio \<22% and/or
* progressive rise of PSA levels in two consecutive blood samples despite antibiotics
Exclusion Criteria:
* antiandrogen therapy
* prostate needle biopsy \<21 days before PET/MRI
* known active secondary cancer
* endorectal coil not applicable (e.g. anus praetor with short rectal stump)
* known active prostatitis (e.g. painful DRE)
* known anaphylaxis against gadolinium-DOTA
* patient's written informed consent not given
* needle biopsy and/or prostatectomy compound not available for histology/immunohistochemistry
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT02659527
Study Brief:
Protocol Section:
NCT02659527